24,25-Dihydroxyvitamin D3 and bone metabolism

Steroids

Volumn 66, Issue 3-5, 2001, Pages 375-380

  Van Leeuwen, Johannes P T M ^a   Van Den Bemd, Gert Jan C M ^a   Van Driel, Marjolein ^a   Buurman, Cok J ^a   Pols, Huibert A P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

24,25 Dihydroxyvitamin D3; Bone; Metabolites; Vitamin D

Indexed keywords

24,25 DIHYDROXYCOLECALCIFEROL; CALCITRIOL; VITAMIN D; VITAMIN D RECEPTOR;

BONE CELL; BONE METABOLISM; CARTILAGE; CARTILAGE CELL; CHICKEN; CONFERENCE PAPER; EGG; HATCHING; HYDROXYLATION; METABOLITE; NONHUMAN; REVIEW;

24,25-DIHYDROXYVITAMIN D 3; ANIMALS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; HUMANS; OSTEOGENESIS;

GALLUS GALLUS;

EID: 0035342729     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(00)00155-0     Document Type: Conference Paper

References (84)

1. Vitamin D in the treatment of osteoporosis
2. Vitamin D in the treatment of osteoporosis revisited
3. Vitamin D for the treatment of osteoporosis
4. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency
5. Is there a differential response to alfacalcidol and vitamin D in the treatment of osteoporosis?
6. 3 and calcium to prevent hip fractures in elderly women
7. Treatment of postmenopausal osteoporosis with calcitriol or calcium [see comments]
8. Absent intestinal response to calciferols in hereditary resistance to 1,25-dihydroxyvitamin D; documentation and effective therapy with high dose intravenous calcium infusions
9. Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D
10. The combined use of intravenous and oral calcium for the treatment of vitamin D dependent rickets type II (VDDRII)
11. Long-term intracaval calcium infusion therapy in end-organ resistance to 1,25-dihydroxyvitamin D
12. 3 receptor in fetal rat bone
13. Demonstration of vitamin D receptor transcripts in actively resorbing osteoclasts in bone sections
14. 3; increased bone but impaired mineralization
15. 3 stimulates bone formation and increases the number of osteoblast precursor cells in bone marrow
16. 3 on bone
17. 3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8
18. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts; dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression
19. 3-analogs on osteoblast-like cells and on in vitro bone resorption
20. 3 enhancement of osteocalcin and osteopontin transcription; reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements
21. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype; dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures
22. 3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells
23. Constitutive expression of calreticulin in osteoblasts inhibits mineralization
24. 3 receptor binding, 24-hydroxylase activity and in vitro bone resorption
25. 3-induced 24-hydroxylase activity in osteoblast-like cells; initiation of the C24-oxidation pathway
26. 3 and synthetic human parathyroid hormone fragment 1-34 in a cloned monkey kidney cell line (JTC-12)
27. 3 and parathyroid hormone
28. 3 is regulated by parathyroid hormone in UMR106 osteoblastic cells [see comments]
29. Vitamin D; two dihydroxylated metabolites are required for normal chicken egg hatchability
30. 3 are both indispensable for calcium and phosphorus homeostasis
31. The effects of vitamin D metabolites on phospholipase A2 activity of growth zone and resting zone cartilage cells in vitro
32. 3 on growth zone and resting zone chondrocyte membrane alkaline phosphatase and phospholipase-A2 specific activities
33. 3 metabolites regulate LTBP1 and latent TGF-β1 expression and latent TGF-β1 incorporation in the extracellular matrix of chondrocytes
34. Calcitriol but no other metabolite of vitamin D is essential for normal bone growth and development in the rat
35. 3 prevent postmenopausal bone loss?
36. 3 metabolites and PTH synergistically stimulate bone formation of chick embryonic femur in vitro
37. 3 on bone remodeling
38. The effect of vitamin D on bone in vivo
39. Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats
40. Effect of vitamin D metabolites on bone metabolism in a rat model of postmenopausal osteoporosis
41. 3; evidence for a nonnuclear membrane receptor in the chick tibial fracture-healing callus
42. 3 metabolite for both normal bone integrity and healing of tibial fracture in chicks
43. 3 levels are correlated with the healing process after chick tibial fracture
44. Serum 24,25-dihydroxyvitamin D and 25-hydroxyvitamin D concentrations in femoral neck fracture
45. 3 in the hypophosphatemic mouse
46. 3 promotes bone formation without causing excessive resorption in hypophosphatemic mice
47. 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets-a clinical research center study
48. 3 in predialysis renal insufficiency; biochemistry and histomorphometry of cancellous bone
49. 3
50. 3 and parathyroid hormone on calcium transport in chick intestine
51. 3 on the formation and function of osteoclastic cells
52. 3 occurs through the vitamin D receptor and the vitamin D-responsive element
53. 3 in cultured human osteoblastic cells
54. 3 metabolism in calcium-deficient rats
55. 3
56. 3 administration on parameters of calcium metabolism
57. Response of chick parathyroid glands to the vitamin D metabolites, 1,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol
58. Inhibition of parathyroid hormone secretion by 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol in the dog
59. 3 dihydroxylated metabolites on parathyroid hormone in the rat. 'In vitro' studies with dispersed rat parathyroid cells
60. 3 in osteoclasts
61. 3 metabolites alters PTH-responsive osteoblastic adenylate cyclase in rats
62. 3 treatment inhibits parathyroid-stimulated adenylate cyclase in iliac crest biopsies from uremic patients
63. 3 on growth, alkaline phosphatase and adenylate cyclase of rat osteoblast-like cells
64. 3 affect parathormone (PTH)-sensitive adenylate cyclase activity and alkaline phosphatase secretion of osteoblastic cells through different mechanisms of action
65. 3 metabolites on cytosolic free calcium in confluent mouse osteoblasts
66. 3 metabolites in confluent mouse osteoblasts
67. 3 modulates the L-type Ca2+ channel current in UMR 106 cells; involvement of protein kinase A and protein kinase C
68. 3 metabolite biologically active in cartilage
69. 3 receptor in the parathyroid gland of the rachitic chick
70. 3 in differentiating skeletal mesenchyme
71. Evidence for 24,25-dihydroxycholecalciferol receptors in long bones of newborn rats
72. 3 in epiphyseal cartilage
73. 3 binding in fetal rat calvariae and osteogenic sarcoma cells
74. Structure-function relationships in the vitamin D endocrine system
75. 3 to vitamin D responsive element of human osteocalcin gene
76. 3 receptors by vitamin D analogs in cultured mammalian cells
77. 3
78. Differential expression of estrogen receptors alpha and beta mRNA during differentiation of human osteoblast SV-HFO cells
79. Estradiol formation by human osteoblasts via multiple pathways; relation with osteoblast function
80. Vitamin D and bone development
81. 24R,25Dihydroxyvitamin D-active metabolite or inactive catabolite?
82. Targeted inactivation of vitamin D hydroxylases in mice